Meningitis can be a frightening diagnosis. Our expert guide breaks down the different types—bacterial, viral, and fungal—and ...

The so-called "meningitis belt" in sub-Saharan Africa sees most cases and outbreaks. It stretches from Senegal and The Gambia in the west of the continent all the way to Ethiopia in the east.

The African meningitis belt is a region of 26 countries in sub-Saharan Africa where the rate of incidence of meningitis is very high.

In sub-Saharan Africa, particularly in the extended meningitis belt from Senegal to Ethiopia, this disease has historically posed a significant threat.

This agreement will fill a significant gap in the prevention and treatment of meningitis in sub-Saharan Africa, particularly in the meningitis belt stretching from Senegal in the west to Ethiopia ...

Meningococcal meningitis is observed worldwide but the highest burden of the disease is in the meningitis belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east.

Nigeria, a prominent nation within Africa's meningitis belt, has taken a monumental step forward in healthcare by launching the world's premier vaccine targeting all strains of meningitis. This ...

Nigeria has rolled out the world's first vaccine against all strains of meningitis. The shot will help ease the burden of disease in Africa's “meningitis belt.” Nigeria has become the first ...

Nigeria has rolled out the world's first vaccine against all strains of meningitis. The shot will help ease the burden of disease in Africa's "meningitis belt." Nigeria has become the first ...

Nigeria is one of the 26 meningitis hyper-endemic countries of Africa, situated in the area known as the African Meningitis Belt.

As one of the 26 countries within the extensive region of sub-Saharan Africa known as the “Meningitis Belt” Nigeria has a long history of Cerebrospinal meningitis epidemic. Cerebrospinal ...

SAGE recommended that all countries in the African meningitis belt introduce the novel pentavalent meningococcal conjugate vaccine targeting serogroups A, C, Y, W and X (Men5CV) into their routine ...